Several anti-TNF-α treatments have prevented Aβ deposition, behavioural impairments and inflammation in AD animal models [36–39], suggesting that TNF-α is a detrimental factor in AD course and can serve as a reliable AD target. This evidence concerns the gene TNF and Alzheimer disease.